GlassScriptPhysician profile
Jaime M Hopper
NPI 1467999151
$911.79
in general payments reported to CMS, 2019-2025
21 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.40 · 2022: $133 · 2023: $223 · 2024: $216 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $121.71 | 2021-2024 | Perclose Proglide, Dragonfly Opstar |
| Cordis US Corp. | $98.51 | 2022-2025 | Mynx Control Venous, Mynx Venous Vcd, Rain Sheath Transradial |
| Novo Nordisk INC | $91.49 | 2023-2024 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $62.26 | 2021-2024 | Brilinta |
| Ironshore Pharmaceuticals INC. | $61.19 | 2023-2024 | Jornay Pm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.10 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $54.89 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $46.61 | 2022 | |
| Biosense Webster, INC. | $45.76 | 2021-2022 | |
| Pfizer INC. | $34.22 | 2024-2025 | |
| Chiesi USA, INC. | $30.25 | 2021-2025 | Kengreal |
| Acist Medical Systems, INC. | $25.34 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.25 | 2023 | Jardiance |
| Teleflex LLC | $22.49 | 2025 | Orsiro Mission |
| Cardiovascular Systems INC. | $21.32 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $20.90 | 2025 | Uptravi, Opsumit |
| W. L. Gore & Associates, INC. | $20.85 | 2025 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $20.77 | 2024 | Ensoetm |
| Medtronic, INC. | $18.93 | 2023 | Onyx Frontier |
| E.R. Squibb & Sons, L.L.C. | $17.00 | 2021 | |
| Terumo Medical Corporation | $16.95 | 2025 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Hopper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.